These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15133374)

  • 1. Should the National Cholesterol Education Program guidelines be changed for persons at high risk for cardiovascular events?
    Aronow WS
    Prev Cardiol; 2004; 7(2):71-2. PubMed ID: 15133374
    [No Abstract]   [Full Text] [Related]  

  • 2. Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?
    Aronow WS
    J Gerontol A Biol Sci Med Sci; 2005 May; 60(5):591-2. PubMed ID: 15972605
    [No Abstract]   [Full Text] [Related]  

  • 3. Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Cholesterol and the aged: ...and the beat goes on.
    Wilson MM
    J Gerontol A Biol Sci Med Sci; 2005 May; 60(5):600-2; author reply 602. PubMed ID: 15972610
    [No Abstract]   [Full Text] [Related]  

  • 4. Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Aim low.
    Nash IS
    J Gerontol A Biol Sci Med Sci; 2005 May; 60(5):599-600; author reply 602. PubMed ID: 15972609
    [No Abstract]   [Full Text] [Related]  

  • 5. Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Commentary.
    Levy DR; Pearson TA
    J Gerontol A Biol Sci Med Sci; 2005 May; 60(5):597-8; author reply 602. PubMed ID: 16094772
    [No Abstract]   [Full Text] [Related]  

  • 6. The 2013 ACC/AHA guidelines on the treatment of blood cholesterol: questions, questions, questions.
    Ginsberg HN
    Circ Res; 2014 Feb; 114(5):761-4. PubMed ID: 24577964
    [No Abstract]   [Full Text] [Related]  

  • 7. Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Hyperlipidemia in seniors: too much, too little, too late?
    Hirth VA
    J Gerontol A Biol Sci Med Sci; 2005 May; 60(5):595-7; author reply 602. PubMed ID: 15972608
    [No Abstract]   [Full Text] [Related]  

  • 8. Application of new cholesterol guidelines to a population-based sample.
    Pencina MJ; Navar-Boggan AM; D'Agostino RB; Williams K; Neely B; Sniderman AD; Peterson ED
    N Engl J Med; 2014 Apr; 370(15):1422-31. PubMed ID: 24645848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-lowering therapy in high-risk persons.
    Aronow WS
    Compr Ther; 2006; 32(2):68-73. PubMed ID: 16845146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Commentary.
    Mooradian AD
    J Gerontol A Biol Sci Med Sci; 2005 May; 60(5):598; author reply 602. PubMed ID: 16094774
    [No Abstract]   [Full Text] [Related]  

  • 11. Statin treatment for older adults: the impact of the 2013 ACC/AHA cholesterol guidelines.
    Weinberger Y; Han BH
    Drugs Aging; 2015 Feb; 32(2):87-93. PubMed ID: 25586520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated National Cholesterol Education Program III guidelines.
    Aronow WS
    J Am Med Dir Assoc; 2005; 6(2):160-1. PubMed ID: 15871897
    [No Abstract]   [Full Text] [Related]  

  • 13. The new National Cholesterol Education Program guidelines: clinical challenges for more widespread therapy of lipids to treat and prevent coronary heart disease.
    Eidelman RS; Lamas GA; Hennekens CH
    Arch Intern Med; 2002 Oct; 162(18):2033-6. PubMed ID: 12374510
    [No Abstract]   [Full Text] [Related]  

  • 14. More than a billion people taking statins?: Potential implications of the new cardiovascular guidelines.
    Ioannidis JP
    JAMA; 2014 Feb; 311(5):463-4. PubMed ID: 24296612
    [No Abstract]   [Full Text] [Related]  

  • 15. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.
    Maddox TM; Borden WB; Tang F; Virani SS; Oetgen WJ; Mullen JB; Chan PS; Casale PN; Douglas PS; Masoudi FA; Farmer SA; Rumsfeld JS
    J Am Coll Cardiol; 2014 Dec; 64(21):2183-92. PubMed ID: 25447259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol guidelines update: more aggressive therapy for higher-risk patients.
    Huang JC; Hoogwerf BJ
    Cleve Clin J Med; 2005 Mar; 72(3):253-62. PubMed ID: 15825805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" What do we do for the very old?
    Goodwin JS
    J Gerontol A Biol Sci Med Sci; 2005 May; 60(5):593-594; author reply 602. PubMed ID: 15972606
    [No Abstract]   [Full Text] [Related]  

  • 18. Deciphering cholesterol treatment guidelines: a clinician's perspective.
    Ganda OP
    JAMA; 2015 Mar; 313(10):1009-10. PubMed ID: 25756432
    [No Abstract]   [Full Text] [Related]  

  • 19. New Cholesterol Guidelines Personalize Risk and Add Treatments.
    Abbasi J
    JAMA; 2019 Feb; 321(8):731-732. PubMed ID: 30725107
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines for cardiovascular risk assessment and cholesterol treatment.
    Lloyd-Jones DM; Goff DC; Stone NJ
    JAMA; 2014 Jun; 311(21):2235. PubMed ID: 24893098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.